Zymeworks Inc. ZYME 深 滬
已收盤 12-24 16:00:00 美东时间
26.86
+0.070
+0.26%
華盛通- 最 高27.28
- 今 開27.11
- 成交量 23.29万股
- 最 低 26.74
- 昨 收 26.79
- 總市值 20.10亿
- 52周最高 28.49
- 市盈率 靜 --
- 換手率 0.31%
- 52周最低 9.03
- 委 比 -68.07%
- 總股本 7483.65万
- 歷史最高 59.03
- 量 比 0.31
- 振 幅 2.02%
- 歷史最低 4.11
- 每 手 1
- 風險率 4.12%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 德银首予Coinbase"买入"评级，目标价340美元；AERO获多家机构首予超配评级；大摩维持苹果"超配"评级，目标价升至315美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从9美元升至10美元；摩根大通：上调Recursion Pharmaceuticals评级至"超配"，目标价从10美元升至11美元
12-18 10:54
美股大行评级 | 博通、Lululemon获10逾家大行上调目标价；好市多、RH遭大行下调目标价
今日重点评级关注：杰富瑞：维持ImmunityBio Inc Ordinary Shares"买入"评级，目标价从8美元升至9美元；B. Riley证券：维持WAVE Life Sciences"买入"评级，目标价从19美元升至37美元
12-15 15:30
Wells Fargo Upgrades Zymeworks to Overweight, Raises Price Target to $33
Wells Fargo analyst Eva Fortea Verdejo upgrades Zymeworks (NASDAQ:ZYME) from Equal-Weight to Overweight and raises the price target from $25 to $33.
12-13 00:29
Zymeworks (ZYME) Receives a Buy from Citi
Citi analyst Yigal Nochomovitz maintained a Buy rating on Zymeworks on December...
12-08 07:55
美股大行评级 | 美鹰服饰、CrowdStrike、迈威尔科技获多家机构上调目标价；ACHC、GitLab、Okta遭多家机构下调目标价
今日重点评级关注：Guggenheim：维持Cybin Inc. Common Shares"买入"评级，目标价从39美元升至48美元；HC Wainwright & Co.：维持Capricor Therapeutics"买入"评级，目标价从24美元升至60美元
12-04 09:38
Citizens Initiates Coverage On Zymeworks with Market Outperform Rating, Announces Price Target of $32
Citizens analyst Reni J. Benjamin initiates coverage on Zymeworks (NASDAQ:ZYME) with a Market Outperform rating and announces Price Target of $32.
12-03 23:58
华尔街顶级分析师最新评级：优步被上调评级
华尔街最受关注、且能影响市场走势的研究评级报告现已汇总。以下是由 The Fly 整理的今日投资者需关注的研究评级信息。 五家评级上调的公司 Arete...
12-03 22:58
Zymeworks Announces Participation in Upcoming Conferences
Zymeworks Inc. announced its participation in upcoming conferences. At the ASCO Gastrointestinal Cancers Symposium (January 8-10, 2026, San Francisco, CA), Zymeworks will present ZW251, a GPC3-targeting ADC for hepatocellular carcinoma. Partner Jazz will highlight Ziihera® in HER2-driven gastrointestinal cancers. Zymeworks' management will also present at the J.P. Morgan Healthcare Conference on January 14, 2026, at 3:00 pm PT. Zymeworks focuses ...
12-02 21:05
美股大行评级 | 最高130美元！11家大行集体上调沃尔玛目标价；戴康工业、Gap、罗斯百货等均或多家大行上调目标价
今日重点评级关注：Canaccord Genuity：维持Fractyl Health"买入"评级，目标价从6美元升至8美元；HC Wainwright & Co.：维持MediWound"买入"评级，目标价从31美元升至36美元
11-24 11:23
Zymeworks Announces Participation in Upcoming Investor Conferences
VANCOUVER, British Columbia, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. announced that its management will participate in two upcoming investor conferences: the Evercore 8th Annual Healthcare Conference on December 2, 2025, and the Citi 2025 Global Healthcare Conference on December 3, 2025, both in Miami, FL. Zymeworks is a global biotechnology company developing innovative biotherapeutics for treating difficult-to-treat diseases such as ca...
11-24 11:00
